Keytruda+Lenvima – ASCO GU Display Banners Conference – 590778
ASCO GU eBook
ASCO Genitourinary Cancer Renal 2022.indd
Alarming Drop in Cancer Screenings Due to Pandemic
A significant drop in the screening, diagnosis and treatment of genitourinary cancers was observed during the early months of the COVID-19 pandemic. Hereafter, a progressive recovery was observed. Notably, the screening rate for...
Large Phase 3 Trial Tests Novel Combinations for Metastatic ccRCC
An ongoing open-label, randomized phase 3 trial (NCT04736706) will determine the efficacy of the...
Rucaparib maintenance therapy extends PFS in platinum-responsive metastatic urothelial carcinoma
Results from the ATLANTIS trial platform indicate that rucaparib could play a role in the maintenance treatment of metastatic urothelial carcinoma with a DNA repair deficiency that has responded to first-line platinum-based...
Pembrolizumab Disease-Free Survival Persists Long Term in RCC
Updated data from the KEYNOTE-564 trial shows pembrolizumab disease-free survival persists long...
Good Response With Nivolumab Plus Axitinib in Metastatic RCC
Combination treatment with nivolumab plus axitinib has achieved a high response rate in...
Biomarkers Predict Response to Immune Nivolumab (± Ipilimumab) in Advanced RCC
Biomarker analysis of the phase 2 TITAN-RCC trial identified specific immune cell-related...
Avelumab Plus Axitinib May Benefit High-Risk Early RCC
Results of the NeoAvAx trial indicate that the neoadjuvant combination of avelumab plus axitinib...
Health and Safety at ASCO GU 2022
Individual Accountability ASCO is committed to maintaining the health and safety of all ASCO Genitourinary Cancers Symposium attendees. We will be reviewing the latest Centers for Disease Control and Prevention and World Health...
Active Surveillance Helps Delay Systemic Therapy in Some With Metastatic Renal Cell Carcinoma
Active surveillance (AS) may be used effectively in a subgroup of patients(pts) with metastatic renal cell carcinoma (RCC) and indolent disease to postpone the commencement of systemic treatment without affecting long-term...
Mindfulness App Helps Address Psychosocial Distress in Patients With Metastatic Renal Cell Carcinoma
mRCC was linked to a high incidence of distress, a high degree of symptom load, and a wide range of quality-of-life impairments. A smartphone application aimed at enhancing mindfulness has been developed from a Mindfulness-Based...
